1. Home
  2. CGEM vs CYD Comparison

CGEM vs CYD Comparison

Compare CGEM & CYD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CGEM
  • CYD
  • Stock Information
  • Founded
  • CGEM 2016
  • CYD 1951
  • Country
  • CGEM United States
  • CYD Singapore
  • Employees
  • CGEM N/A
  • CYD N/A
  • Industry
  • CGEM Biotechnology: Pharmaceutical Preparations
  • CYD Industrial Machinery/Components
  • Sector
  • CGEM Health Care
  • CYD Industrials
  • Exchange
  • CGEM Nasdaq
  • CYD Nasdaq
  • Market Cap
  • CGEM 530.0M
  • CYD 609.7M
  • IPO Year
  • CGEM 2021
  • CYD 1994
  • Fundamental
  • Price
  • CGEM $7.67
  • CYD $21.17
  • Analyst Decision
  • CGEM Strong Buy
  • CYD
  • Analyst Count
  • CGEM 5
  • CYD 0
  • Target Price
  • CGEM $30.00
  • CYD N/A
  • AVG Volume (30 Days)
  • CGEM 324.5K
  • CYD 169.4K
  • Earning Date
  • CGEM 08-07-2025
  • CYD 08-11-2025
  • Dividend Yield
  • CGEM N/A
  • CYD 2.53%
  • EPS Growth
  • CGEM N/A
  • CYD 17.49
  • EPS
  • CGEM N/A
  • CYD 1.12
  • Revenue
  • CGEM N/A
  • CYD $2,621,360,849.00
  • Revenue This Year
  • CGEM N/A
  • CYD $6.43
  • Revenue Next Year
  • CGEM N/A
  • CYD $11.20
  • P/E Ratio
  • CGEM N/A
  • CYD $19.30
  • Revenue Growth
  • CGEM N/A
  • CYD 6.03
  • 52 Week Low
  • CGEM $6.85
  • CYD $8.42
  • 52 Week High
  • CGEM $21.01
  • CYD $26.10
  • Technical
  • Relative Strength Index (RSI)
  • CGEM 38.41
  • CYD 66.06
  • Support Level
  • CGEM $8.47
  • CYD $19.09
  • Resistance Level
  • CGEM $9.25
  • CYD $22.46
  • Average True Range (ATR)
  • CGEM 0.45
  • CYD 1.01
  • MACD
  • CGEM -0.12
  • CYD 0.30
  • Stochastic Oscillator
  • CGEM 5.06
  • CYD 77.33

About CGEM Cullinan Oncology Inc.

Cullinan Therapeutics Inc is a biopharmaceutical company. It has a diversified portfolio of clinical-stage assets that inhibit key drivers of disease or harness the immune system to eliminate diseased cells in both oncology and autoimmune diseases. Its understanding of oncology, immunology, and translational medicine, creates differentiated ideas, identifies the appropriate targets, and selects the optimal modality to develop transformative therapeutics across a variety of cancer and autoimmune indications. It has one reporting and one operating segment, which is the business of developing immunology and oncology therapies.

About CYD China Yuchai International Limited

China Yuchai International Ltd is a Bermuda holding company that is a subsidiary of Singapore-based Hong Leong Asia. China Yuchai International primarily operates through its majority-owned subsidiary Guangxi Yuchai Machinery Company, a China-based company that manufactures, assembles, and distributes diesel engines for various vehicles including trucks, buses, and cars, as well as construction and agricultural, marine, and power-generation equipment. It generates the majority of its sales from the Chinese market.

Share on Social Networks: